Xiao Huang, MD, PHD
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2010 | University of South Carolina, Columbia, South Carolina, US, Biochemistry, Ph. D |
| 2003 | Xiangya Medical University, Changsha, China, CN, Medicine, M. D |
Postgraduate Training
| 2019-2020 | Fellow in Breast Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2018-2019 | Fellow in Cytopathology, Northwestern University, Chicago, Illinois |
| 2016-2018 | Resident in Pathology, Northwestern University, Chicago, Illinois |
| 2014-2016 | Resident in Pathology, George Washington University, Washington, DC |
Licenses & Certifications
| 2024 | State of Texas |
| 2020 | State of Alabama |
| 2019 | Cytopathology |
| 2019 | State of Texas |
| 2018 | State of Illinois |
| 2018 | Anatomic and Clinical Pathology |
| 2016 | State of Illinois |
| 2014 | Washington, D.C |
Experience & Service
Faculty Academic Appointments
Associate Scientist, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama, 2022 - 2025
Associate Scientist, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, 2022 - 2025
Associate Scientist, O'Neal Comprehensive Cancer Center, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, 2021 - 2025
Assistant Professor, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, 2020 - 2025
Other Professional Positions
Co-Principal Investigator, Roswell Park Cancer Institute, Buffalo, New York, 2013 - 2014
Observership, Roswell Park Cancer Institute, Buffalo, New York, 2012 - 2012
Assistant Professor, Hunan Cancer Hospital, Changsha, 2003 - 2005
Intramural Institutional Committee Activities
Member, Institutional Review Committee (IRB), The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Extramural Institutional Committee Activities
member, Center for Women’s Reproductive Health (CWRH), The University of Alabama at Birmingham, 2022 - 2025
member, National Accreditation Program for Breast Centers (NAPBC), The University of Alabama at Birmingham, 2022 - 2025
member, Women’s health recruit, department of pathology, The University of Alabama at Birmingham, 2022 - 2025
member, Anatomic pathology task force, the University of Alabama at Birmingham, 2022 - 2023
Editorial Activities
Editor's Academy, Membership, Modern Pathology, 2026 - 2028
Reviewer, United States and Canadian Academy of Pathology Abstract Review Board in the Breast Pathology, 2024 - 2027
Section Editor, Human Pathology Report, 2023 - Present
Honors & Awards
| 2025 | Gilead Research Scholar Award (submitted, collaborator), “Defining the role of PU.1 in breast cancer macrophage to myofibroblast transition” |
| 2020 | International Society of Breast Pathology (ISBP) and the Breast Cancer Research Foundation (BCRF) Award, United States and Canadian Academy of Pathology |
| 2019 - 2020 | Goldberg Family Charitable Trust Fund, Northwestern University |
| 2015 - 2016 | Ghassan Haidar Memorial Award, George Washington University |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2023. Mutations in Homologous Recombination Repair Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Invited. Chicago, IL, US.
- 2022. Invited speaker, Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast Carcinoma. Invited. Chicago, IL, US.
International Presentations
- 2026. Short course: Mastering the Rare but Clinically Significant Histologic Subtypes of Breast Cancer with Favorable Prognosis. Invited. San Antonio, US.
- 2024. Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Invited, US.
- 2023. Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Invited. Dubai, AE.
- 2023. Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Invited, US.
Formal Peers
- 2023. Uncommon breast cancers diagnosed on surgical pathologic and cytopathologic specimens. Chicago, IL, US.
- 2022. Rare and salivary gland-type tumors of the breast, cases and literature reviews. Chicago, IL, US.
Grant & Contract Support
| Date: | 2026 - 2030 |
| Title: | Defining the impact of PU.1 on cancer-associated fibroblast and tumor-associated macrophage function, their transdifferentiation, and clinical outcome |
| Funding Source: | NIH NCI |
| Role: | Co-I |
| Date: | 2026 - 2029 |
| Title: | Defining the impact of PU.1 on cancer-associated fibroblast and tumor-associated macrophage function, their transdifferentiation, and clinical outcome |
| Funding Source: | American Cancer Society Research Scholar Grant |
| Role: | Co-I |
| Date: | 2025 - 2028 |
| Title: | Defining the Role of PU.1 in Breast Cancer Macrophage to Myofibroblast Transition |
| Funding Source: | : Department of Defense Breast Cancer Research Program |
| Role: | Co-I |
| Date: | 2021 - 2021 |
| Title: | Comparison of PD-L1 Expression between Primary Triple Negative Breast Cancer and Matched Distant Metastases Correlating with p53 Status |
| Funding Source: | Department of Pathology Pilot/Feasibility Clinical Research Grant |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Han, J, Ding, Y, Gan, Q, Sweeney, K, Huang, X, Hameed, N, Weissferdt, A, Wang, Y, Peng, Y, Sun, H. TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms. Human Pathology 177, 2026. e-Pub 2026. PMID: 42398545.
- Huang X, Fadel H, Yang RK, Okamoto K, Harada S, Wang J, Chen H, Huo L, Lim B, Bassett Jr RL, Wei S, Sweeney K, Albarracin CT, Sahin AA. An ARID1A mutation affects treatment response with a CDK4/6 inhibitor in patients with ER-positive/HER2-negative metastatic breast carcinomas. e-Pub 2026.
- Huang X, Anderson SA, Zhou M, Zhang K, Okamoto K, Dal Zotto VL, Harada S, Kahn AG, Wei S. Revisiting HER2-negative Breast Cancer (BC) in the Era of HER2-low and HER2-ultralow Expression: Assessment of Interobserver Variability. The Breast. e-Pub 2026.
- Khoury T, Zhan H, Huang X, Ghasemi F, Rajack F, Yuan G, Yu H, Theriot J, Bragiel R, Okamoto K, Ali M. Predicting the Probability of Residual Axillary Nodal Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Modern Pathology, 2025. e-Pub 2025. PMID: 41043643.
- Huang X, Varambally S, Anderson SA, Bartow BB, Harada S, Wei S, Siegal GP, Khoury K, Yalniz C. A Genomic Alteration in GATA3 Affects Treatment Responses With a CDK4/6 Inhibitor Collaborating With p18INK4C Expression in Advanced Breast Carcinoma. Modern Pathology, 2025. e-Pub 2025. PMID: 40680849.
- Anderson AS, Bartow BB, Siegal PG, Harada S, Khoury K, Yalniz C, Huo L, Ding Q, Sahin AA, Huang X. Predictive Biomarkers for Immune Checkpoint Inhibitor (ICI) and Poly (ADP-Ribose) Polymerase (PARP) Inhibitors (PARPi) in Advanced Stage Breast Carcinoma. Human Pathology Report 40, 2025. e-Pub 2025. PMID: 300775.
- Goksel M, Patel RC, Anderson AS, Carames GP, Moultrie SS, Maig-Galluzzi C, Wei S, Huang X. Utilization of NKX3.1 and P501S to Distinguish Primary Breast Carcinoma from Metastatic Prostatic Adenocarcinoma in Male Patients. Virchows Archiv, 2025. e-Pub 2025. PMID: 40347269.
- Huang X, Harada S, Wei S, Siegal GP, Anderson SA, Sahin AA, Khoury K, Yalniz C. Association between p16/INK4A Expression and a Treatment Response with a CDK4/6 Inhibitor in Advanced Breast Carcinoma. Human Pathology, 2025. e-Pub 2025. PMID: 40780613.
- Sara Ranjbar, Pingjun Chen, Khushali P Shah, Anthony San Lucas, Caner Ercan, Elizve Barrientos Toro, Karina Pinao, Keith J Sweeney, Huang X, Yasin Shokrollahi, Michael Suchko, Jessica DeLa Cruz, Bella Guerrouahen, B. Leticia Rodriguez, Neelima G Reddy, Xiaoxi Pan, Clinton Yam, Roberto Salgado, Donna E Hansel, Geeta S Mantha, Lei Huo, Michael W Riben, Yinyin Yuan. A Roadmap for Pathology AI Clinical Integration: Lessons Learned from Promise to Practice. The Lancet Digital Health. e-Pub 2025.
- Chen S, Oramas Mogrovejo DM, Huang X, Siegal GP, Wei S. Reduced GATA3 expression during breast cancer progression: a potential anchor for pulmonary metastatic deposition. Pathology-Research and Practice, 2025. e-Pub 2025. PMID: 39817957.
- Anderson AS, Bartow BB, Harada S, Siegal GP, Wei S, DalZotto VL, Huang X. p53 Protein Expression Patterns Associated with TP53 mutations in Breast Carcinoma. Breast cancer Research and Treatment 204:213-222, 2024. e-Pub 2024. PMID: 38900212.
- Li X, Nguyen TTA, Zhang J, Liu Y, Duckworth LA, Zhang G, Bakkar R, Agarwal I, Hou Y, Guo H, Huang X, Wei S, Yasmeen S, Thaer K, Zhang H, Smith GH, Turashvili G, Peng L, Liu Y, Yang W, Siziopikou KP. Validation of the newly proposed revised diagnostic criteria for malignant phyllodes tumor with 136 borderline and malignant phyllodes tumor cases. American Journal of Surgical Pathology 48(9):1146-1153, 2024. e-Pub 2024. PMID: 38934254.
- Salem A, Wu Y, Albarracin CT, Middleton LP, Kalhor N, Peng Y, Huang X, Aung PP, Chen H, Sahin AA, Ding QQ. A Comparative Evaluation of TRPS1 and GATA3 in Adenoid Cystic, Acinic Cell, and Secretory Carcinomas of the Breast and Salivary Glands. Human Pathology 145:42-47, 2024. e-Pub 2024. PMID: 38262580.
- Huang X, Yang JY, Pickens J.T, Huo L, Sahin AA, Granada CP, Wei S, Chen SJ. Comparison of PD-L1 (22C3) expression in paired primary and metastatic breast carcinoma. Clinical Breast Cancer 24(4):310-318, 2024. e-Pub 2024. PMID: 38492995.
- Anderson SA, Bartow BB, Siegal GP, Huang X, Wei S. The Dynamics of HER2-low Expression during Breast Cancer Progression. Breast cancer Research and Treatmen 201:437-446, 2023. e-Pub 2023. PMID: 37433993.
- Anderson SA, Harbi D, Oramas Mogrovejo DM, Eltoum IA, Fatima H, Rosenblum F, Lora Gonzalez MA, Lin D, Mackinnon A, Siegal GP, Harada S, Huang X. PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features in Lung Adenocarcinomas in Cytological Samples. Acta Cytologica 67(5):507-518, 2023. e-Pub 2023. PMID: 37494911.
- Bartow BB, Siegal GP, Huo L, Ding QQ, Sahin AA, Harada S, Huang X. Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced Stage Breast Carcinoma. Cancers (Basel) 15:2524, 2023. e-Pub 2023. PMID: 37173992.
- Chang JC, Li P, Harada S, Arend RC, Diffalha SAL, Kahn AG, Mackinnon A, Pesoli C, Siegal GP, Huang X. PD-L1 (22C3) expression and molecular alterations in ovarian carcinomas. Clinics in Surgery 2023(8):3629, 2023. e-Pub 2023.
- Ye QQ, Chen H, Han C, Peng Y, Huang X, Sun HX, Wu Y, Albaracin TC, Middleton PL, Sahin AA, Huo L, Ding QQ. Nuclear Staining for Pan-Trk by Immunohistochemistry Is Highly Specific for Secretory Carcinoma of breast: Pan-Trk in Various Subtypes of Breast Carcinoma. Journal of Clinical Pathology 0:1-5, 2023. e-Pub 2023. PMID: 37586834.
- Yoon EC, Wang G, Parkinson B, Huo, L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Human Pathology 125:97-107, 2022. e-Pub 2022. PMID: 35413381.
- Mejbel H, Harada S, Stevens T, Huang X, Netto G, Mackinnon A, Al Diffalha S. Spindle Cell Sarcoma of the Uterus Harboring MEIS1::NCOA1 Fusion Gene and Mimicking Endometrial Stromal Sarcoma. International Journal of Surgical Pathology, 2022. e-Pub 2022. PMID: 35477326.
- Huang X, Chen H, Ding Q, Robinson MK, Moseley TW, Bassett RL, Tang G, Sahin AA. Clinicopathology features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma. Human Pathology 117:51-59, 2021. e-Pub 2021. PMID: 34363799.
- Huang X, Ding Q, Guo H, Gong Y, Zhao J, Zhao M, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple negative breast carcinoma. Human Pathology 108:42-50, 2021. e-Pub 2021. PMID: 33221342.
- Chowsilpa S, An D, Lose H, Huang X, Nayar R, Maleki Z. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study. Cancer Cytopathology 127:377-389, 2019. e-Pub 2019. PMID: 31116514.
- Huang X, Lin X. Management of Patients with Renal Mass Lesions Based on Renal Biopsy Cytology Results. Human Pathology 85:270-278, 2019. e-Pub 2019. PMID: 30500417.
- Huang X, Nayar R, Zhou H. Primary Adrenal Gland Epithelioid Sarcoma: A case report and literature review. Diagnostic Cytopathology 47(9):918-921, 2019. e-Pub 2019. PMID: 31087789.
- Reyes MCD, Huang X, Bain A, Ylagan L. Primary Pancreatic Leiomyosarcoma with Metastasis to the Liver Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration: A Case Report and Review of Literature. Diagnostic Cytopathology 44(12):1070-73, 2016. e-Pub 2016. PMID: 27455910.
- Khoury T, Huang X, Chen X, Wang D, Opyrchal M. Comprehensive Histologic Scoring to Maximize the Predictability of Pathology-generated Equation of Breast Cancer Oncotype DX Recurrence Score. Appl Immunohistochem Mol Morphol 24(10):703-711, 2016. e-Pub 2016. PMID: 26808126.
- Huang X, Neppalli, V, Xu B. Metastatic Pancreatic Carcinoma to a Lymph Node with Diffuse Large B Cell Lymphoma: A case report and review of literature. Int J Cancer Clin Res 3:045, 2016. e-Pub 2016.
- Huang X, Wang C, Celeste LR, Lovelace LL, Sun S, Dawson JH, Lebioda L. Complex of myoglobin with phenol bound in a proximal cavity. Acta Crystallographica 12:1465-71, 2012. e-Pub 2012. PMID: 23192025.
- Du, J, Huang X, Sun S, Wang C, Lebioda L, Dawson JH. Amphitrite ornata dehaloperoxidase (DHP): investigations of structural factors that influence the mechanism of halophenol dehalogenation using "peroxidase-like" myoglobin mutants and "myoglobin-like" DHP mutants. Biochemistry 50(38):8172-80, 2011. e-Pub 2011. PMID: 21800850.
- Huang X, Gibson LM, Bell BJ, Lovelace LL, Pena MO, Berger FG, Berger SH, Lebioda L. Replacement of Val3 in Human Thymidylate Synthase Affects Its Kinetic Properties and Intracellular Stability. Biochemistry 49(11):2475-2482, 2010. e-Pub 2010. PMID: 20151707.
Invited Articles
- Sahin A, Chen H, Huang X, Senthil D, Meric-Bernstam F. Emerging Molecular Therapeutic Targets in Breast Cancer: Pathologic Identification and Clinical Implications. Human Pathology, 2026. e-Pub 2026. PMID: 105881.
Abstracts
- Huang X, Okamoto K, Harada S, Yang RK, Chen H, Wang J, Huo L, Wei S, Sweeney KJ, Albarracin CT, Sahin AA. Impact of ARID1A mutations and GATA3 mutations in metastatic ER-positive/HER2-negative breast carcinoma. USCAP 2026 annual meeting, 2026. e-Pub 2026.
- Chen H, Wang Z, Ding QQ, Perkins B, Liu A, Sweeney KJ, Roy-Chowdhuri S, Huang X, Damodaran S, Huo L. Utility of PTEN Copy Number Variation by Next Generation Sequencing in Detecting PTEN Loss in Triple Negative Breast Cancer. USCAP 2026 annual meeting.
- Anderson SA, Harbi D, Mogrovejo DO, Floyd AD, Eltoum I, Fatima H, Rosenblum F, Gonzalez ML, Lin D, Mackinnon AC, Siegal GP, Harada S, Huang X. PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features of Lung Adenocarcinomas in Cytological Samples. USCAP 2023 annual meeting.
- Vidal ID, Joseph KB, Fatima H, Rosenblum F, Eltoum I, Huang X, Gonzalez ML, Lin D. Concordance for Cerebrospinal Fluids: Can Cytotechnologists Sign-out more?. USCAP 2023 annual meeting.
- Bartow BB, Siegal GP, Huo L, Sahin A, Harada S, Huang X. Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced Stage Breast Carcinoma. USCAP 2023 annual meeting.
- Bartow BB, Chang JC, Siegal GP, Arend R, Kahn AG, Al Diffalha S, Mackinnon AC, Pesoli CC, Harada S, Huang X. Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Epithelial Ovarian Carcinoma. USCAP 2023 annual meeting.
- Anderson SA, Bartow BB, Huang X, Wei S. The Dynamic of HER2-low Expression during Breast Cancer Progression. USCAP 2023 annual meeting.
- Rosenblum F, Gonzalez ML, Lin D, Huang X, Eltoum IE, Fatima H, Davis FA. Improving Efficiencies for Rapid On-Site Evaluation for Endobronchial Ultrasound Cases: How Many Passes are needed to Achieve Adequacy?. ASC's 71th Annual Scientific Meeting 2023.
- Rosenblum F, Gonzalez ML, Lin D, Huang X, Eltoum IE, Fatima H. Does Absence of Transformation Zone Component in Anal Cytology Sample Affects Detection of Squamous Intraepithelial Lesions?. ASC's 71th Annual Scientific Meeting 2023.
- Batra H, Barrientos EN, Guo H, Huang X, Raso MG, Ding Q, Lei H. PD-L1 Expression by Immunohistochemistry: Comparison Between Tissue Microarrays and Whole Slide Sections in Breast Carcinoma. USCAP 2023 annual meeting.
- Joseph KB, Vidal ID, Floyd AD, Fatima H, Rosenblum F, Eltoum I, Huang X, Gonzalez ML, Lin D. No Pap Left Behind: Pathologist-Cytotechnologist Concordance in Diagnosing Negative Anal Papanicolaou Smears. USCAP 2023 annual meeting.
- Chen S, Oramas Mogrovejo DM, Huang X, Siegal GP, Wei S. Reduced GATA3 expression during breast cancer progression: a potential anchor for pulmonary metastatic deposition. CAP 2024 Annual Meeting.
- Anderson AS, Bartow BB, Harada S, Siegal GP, Wei S, DalZotto VL, Huang X. Protein Expression Patterns Associated with TP53 mutations in Breast Carcinoma. USCAP 2024 annual meeting.
- Li X, Nguyen TTA, Zhang J, Nayak A, Liu Y, Duckworth LA, Zhang G, Bakkar R, Agarwal I, Hou Y, Guo H, Huang X, Wei S, Yasmeen S, Thaer K, Zhang H, Smith GH, Turashvili G, Peng L, Liu Y, Yang W, Siziopikou KP. Validation of the newly proposed revised diagnostic criteria for malignant phyllodes tumor with 136 borderline and malignant phyllodes tumor cases. USCAP 2024 Annual Meeting.
- Anderson, AS Bartow BB, Siegal PG, Harada S, Khoury K, Yalniz C, Huo L, Ding Q, Sahin AA, Huang X. Predictive Biomarkers for Immune Checkpoint Inhibitor (ICI) and Poly (ADP-Ribose) Polymerase (PARP) Inhibitors (PARPi) in Advanced Stage Breast Carcinoma. USCAP 2024 annual meeting.
- Vidal ID, Rosenblum F, Eltoum I, Fatima H, Huang X, Lin D. Can We Do Better Than Atypical? Analysis of Salivary Glands and Neck Aspirates in a Tertiary Academic Center. CAP 2024 annual meeting.
- Sun H, Zheng L, Huang X, Han C, Liu J, Wu Y, Ding QQ. A Comparison of Three TRPS1 Antibodies in Detecting TRPS1 Expression in Breast Carcinoma and Ovarian Serous Carcinoma. USCAP 2025 Annual Meeting.
- Anderson, AS Bartow BB, Varambally S, Otali D, Harada S, Wei S, Siegal PG, Khoury K, Yalniz C, Huang X. A Truncating Mutation of the GATA3 Gene Affects the Treatment Response with a CDK4/6 Inhibitor via p18/INK4C Expression in Advanced Breast Carcinoma. USCAP 2025 Annual Meeting.
- Anderson, AS Bartow BB, Harada S, Wei S, Siegal PG, Khoury K, Yalniz C, Huang X. Association between p16/INK4A Expression and a Treatment Response with a CDK4/6 Inhibitor in Advanced Breast Carcinoma. USCAP 2025 Annual Meeting.
- Perkins B, Liu A, Ding QQ, Wang Z, Sweeney KJ, Roy-Chowdhuri S, Huang X, Huo L, Clinton Y, Damodaran S, Chen H. PTEN Protein Expression and PI3K Pathway Genomic Alterations in Triple Negative Breast Cancer. USCAP 2026 annual meeting.
- AI-Refai R, Perrier A, Ding QQ, Huang X, Sun H, Ai D, Hunt K, Lillemoe HA, Sahin AA. Clinicopathologic Features and Outcomes of Phyllodes Tumors in Women Under 40 Years: A Single-Institution Cohort of 286 Cases. USCAP 2026 annual meeting.
- Huang X, Gibson L, Bell B, Lovelace L, Berger S, Lebioda L. Structure of Human Thymidylate Synthase (hTS) Mutants at Position Three. Mid-Atlantic Crystallography meeting.
- Chen X, Wang D, Huang X, Liu S, Khoury T. The rate of upgrade for various types of mammary atypia in mammographically detected lesions: a study of 347 cases. USCAP 2014 annual meeting.
- Kumar P, Chen X, Huang X, Wang D, Liu S, Khoury T. The Rate of Upgrade for Mammary Atypia in MRI-Guided Core Needle Biopsy: A Single Institution Experience. USCAP 2014 annual meeting.
- Karabakhtsian R, Sanati S, Kumar P, Reig B, Chen X, Huang X, Wang D, Liu S, Khoury T. The Rate of Upgrade for Mammary Atypia in MRI-Guided Core Needle Biopsy: a Study of 108 Cases from Three Different Institutions. USCAP 2014 annual meeting.
- Sanati S, Karabakhtsian R, Li Z, Desouki M, Reig B, Kumar P, Chen X, Wang D, Huang X, Liu S, Khoury T. Historadiologic Factors to Predict an Upgrade for Atypical Ductal Hyperplasia Diagnosed on an MRI-Guided Core Needle Biopsy: A Study of 46 Cases from Four Institutions. USCAP 2014 annual meeting.
- Desouki M, Karabakhtsian R, Sanati S, Li Z, Reig B, Kumar P, Chen X, Wang D, Huang X, Liu S, Khoury T. The Rate of Upgrade for Lobular Neoplasia in MRI-Guided Core Needle Biopsy: A Study of 63 Cases from Four Different Institutions. USCAP 2014 annual meeting.
- Huang X, Chen X, Wang D, Liu S, Khoury T. The rate of upgrade for pure ADH, pure FEA and Mixed ADH/FEA in mammographically detected lesions: a study of 249 cases. USCAP 2014 annual meeting.
- Huang X, Nolan N, Lu D. A Thyroglossal Duct Cyst of the Superior Mediastinum with Concurrent Ectopic Parathyroid. CAP 2015 annual meeting.
- Huang X, Chauhan S. Eosinophilic myocarditis: a case report and review of literature. CAP 2015 annual meeting.
- Huang X, Qiu J, Xu B. Differential Expression of PAX-8 between Normal Urothelium and Urothelial Carcinoma in Upper and Lower Urinary Tract. CAP 2015 annual meeting.
- Huang X, Ylagan L, Meyes MCD, Kanehira K. Primary Pancreatic Leiomyosarcoma: A Case Report And Literature Review. CAP 2016 annual meeting.
- Huang X, Zhou H. Primary adrenal gland epithelioid sarcoma. ASCP 2017 annual meeting.
- Huang X, Lin X. Impact of Biopsy on Management of Renal Lesions. USCAP 2017 annual meeting.
- Huang X, Blanco L, Nayar R, Zhou H. Conversion of Estrogen Receptor Expression is Common in Malignant Pleural Fluid of Breast Cancer Patients. USCAP 2018 annual meeting.
- Huang X, Blanco L, Siziopikou K, Pincus J. PDL-1 and P53 expression pattern in invasive ductal carcinoma with neuroendocrine features. USCAP 2018 annual meeting.
- Chowsilpa S, An D, Lose H, Huang X, Nayar R, Maleki Z. The Cytomorphology Subtypes of Salivary Gland Neoplasm of Uncertain Malignant Potential (SUMP) in Milan System Carry a Significant Difference in Risk of malignancy (ROM): A Bi-institutional Study. ASC 2018 annual meeting.
- Huang X, Blanco L, Siziopikou K, Pincus J. PD-L1, P53, and mismatch repair protein (MMR) expression patterns in invasive breast carcinoma with neuroendocrine features (IBCN). CAP 2019 annual meeting.
- Huang X, Yang G, Nayar R. Distinct expression pattern of PDL-1 in primary and metastatic colorectal carcinoma and correlated with Microsatellite instability status. USCAP 2019 Annual Meeting.
- Huang X, Ding Q, Guo H, Sui D, Gong Y, Wu Y, Chen H, Wang WB, Huo L. Comparison of three FDA approved PD-L1 immunohistochemistry assays in triple negative breast carcinoma. USCAP 2020 Annual Meeting.
- Huang X, Chen H, Ding Q, Robinson MK, Bassett RL, Tang G, Sahin AA. Clinicopathology features of HER2-Positive classic invasive lobular carcinoma. USCAP 2020 annual meeting.
- Prieto Granada CN, Yang J, Pickens JT, Huo L, Sahin A, Chen S, Wei S, Chkheidze R, Huang X. Correlation of PD-L1 (22C3) and p53 Immunohistochemical Expression Patterns in Paired Primary and Metastatic Breast Carcinoma. USCAP 2022 annual meeting.
- Rosenblum F, Gonzalez ML, Fatima H, Lin D, Huang X, Eltoum IE. Use of Cumulative Sum in the Assessment of Diagnostic Competency of Cytopathology Fellows. ASC's 70th Annual Scientific Meeting.
- Gonzalez ML, Rosenblum F, Fatima H, Lin D, Huang X, Damasceno-Vidal I, Eltoum IE. Analysis of non-diagnostic salivary gland and neck aspirates in a tertiary care academic center. ASC's 70th Annual Scientific Meeting.
- Gonzalez ML, Rosenblum F, Fatima H, Lin D, Huang X, Damasceno-Vidal I, Eltoum IE. Accuracy and Interobserver Agreement in High Risk HPV RNA Chromogenic In-situ Hybridization on Cell Blocks from Metastatic Oropharyngeal Squamous Cell Carcinoma. ASC's 70th Annual Scientific Meeting.
- Chang JC, Harada S, Arend R, Al Diffalha S, Kahn AG, Mackinnon AC, Pesoli CC, Huang X. PD-L1 (22C3) Expression and Molecular Alterations in Ovarian Carcinomas. USCAP 2022 annual meeting.
Book Chapters
- Sahin A, Tamirisa N, Huang X. 2. Tumor Pathology and Molecular Biology in Older Patients. In: Contemporary Approaches to Breast Cancer Management in Older Adults.
Patient Reviews
CV information above last modified August 18, 2026